Innolink Fund logo

Innolink Fund

Asia, Beijing, China, Haidian

Description

Innolink Fund is committed to enabling innovation empower traditional industries & deeply implements the investment layout strategy of ACE

Investor Profile

Innolink Fund has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (75%)
  • Private Equity (25%)

Country Focus

  • China (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Genetics
  • Life Science
  • Medical Device
  • Robotics
  • Beauty
  • Hospital
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Innolink Fund frequently co-invest with?

Co-Investments: 1
DC
North America, Arizona, United States, Scottsdale
Co-Investments: 1
Linden Asset
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Jinyi Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 2
IMO Ventures
North America, California, United States, San Mateo
Co-Investments: 1
Chimera Investment
Asia, Abu Dhabi, United Arab Emirates, Abu Dhabi
Co-Investments: 1
Keyuan Industry Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
MF
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Innolink Fund?

Boundary Intelligent Control

Shenzhen, Guangdong, China

Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft.

Air TransportationArtificial Intelligence (AI)Manufacturing
Series AApr 5, 2025
Amount Raised: $6,851,380
Ruipeng Pet Healthcare

Shenzhen, Guangdong, China

Ruipeng Pet Hospital is a Shenzhen-based pet medical and beauty care hospital operator.

BeautyHealth CareHospitalMedical
Private EquityDec 23, 2022
Abogen Biosciences

Suzhou, Jiangsu, China

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.

BiotechnologyGeneticsLife Science
Series CNov 29, 2021
Amount Raised: $300,000,000
Edge Medical Robotics

Shenzhen, Guangdong, China

Edge Medical Robotics is a surgical robot platform company focused on design, R&D, and commercialization of advance medical devices.

Health CareMedical DeviceRobotics
Series CNov 5, 2021
Amount Raised: $200,000,000
Peijia Medical

Nanjing, Jiangsu, China

Peijia Medical is an interventional medical products provider

Health Care
Series CNov 6, 2019
Amount Raised: $100,000,000